Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Preferred Dividend Payments (2023 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Preferred Dividend Payments for 3 consecutive years, with $118158.0 as the latest value for Q1 2025.

  • On a quarterly basis, Preferred Dividend Payments changed 0.23% to $118158.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $483578.0, a N/A change, with the full-year FY2024 number at $483301.0, up 118.97% from a year prior.
  • Preferred Dividend Payments was $118158.0 for Q1 2025 at 60 Degrees Pharmaceuticals, down from $130968.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $130968.0 in Q4 2024 to a low of $101538.0 in Q3 2023.
  • A 3-year average of $117453.3 and a median of $117881.0 in 2024 define the central range for Preferred Dividend Payments.
  • Peak YoY movement for Preferred Dividend Payments: increased 14.81% in 2024, then grew 0.23% in 2025.
  • 60 Degrees Pharmaceuticals' Preferred Dividend Payments stood at $119176.0 in 2023, then grew by 9.89% to $130968.0 in 2024, then dropped by 9.78% to $118158.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Preferred Dividend Payments are $118158.0 (Q1 2025), $130968.0 (Q4 2024), and $116571.0 (Q3 2024).